Medical Devices Japan

Japan Left Atrial Appendage Closure Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Japan Left Atrial Appendage Closure Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $114.0 Mn Placeholder estimate
Estimate 2025 $132.5 Mn 6.2% of the global market
Projected 2034 $511.6 Mn 286.2% Adds $379.1 Mn over 9 forecast years
CAGR 2025–2034 16.2% Faster than 89% of 173 Medical Devices markets here
Key players 5
  • Japan is 6.15% of the global market.
  • In APAC, the largest is China at $158.8 Mn.
  • Fastest growing: India at 19% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$379.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Left Atrial Appendage Closure Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $114.0 Mn — —
2025 (base) $132.5 Mn +$18.5 Mn —
2026 (forecast) $153.9 Mn +$21.5 Mn +16.2%
2027 (forecast) $178.9 Mn +$24.9 Mn +35%
2028 (forecast) $207.8 Mn +$29.0 Mn +56.9%
2029 (forecast) $241.5 Mn +$33.7 Mn +82.3%
2030 (forecast) $280.6 Mn +$39.1 Mn +111.9%
2031 (forecast) $326.1 Mn +$45.5 Mn +146.2%
2032 (forecast) $378.9 Mn +$52.8 Mn +186.1%
2033 (forecast) $440.3 Mn +$61.4 Mn +232.4%
2034 (forecast) $511.6 Mn +$71.3 Mn +286.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Left Atrial Appendage Closure Market Analysis at a glance
Market size, 2025$132.5 Mn placeholder estimate
Forecast, 2034$511.6 Mn placeholder estimate
Growth (CAGR), 2025–203416.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersBoston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical, Lifetech Scientific (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Left Atrial Appendage Closure Market Analysis Executive Summary

Left atrial appendage closure devices seal off a small pouch in the heart to lower stroke risk in people with atrial fibrillation.

Key segments of the left Atrial Appendage Closure market include product (Endocardial Devices and Epicardial Devices) and setting (Hospitals and Cardiac Centers).

Bar chart: Japan Left Atrial Appendage Closure market size, 2024–2034, placeholder estimates. $114.0 Mn in 2024, $132.5 Mn in 2025 and $511.6 Mn in 2034, 16.2% CAGR.
Japan Left Atrial Appendage Closure market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Left Atrial Appendage Closure Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the left Atrial Appendage Closure market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the left Atrial Appendage Closure market.

Competitive Landscape for Left Atrial Appendage Closure Market in Japan

The left Atrial Appendage Closure market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Left Atrial Appendage Closure Market in Japan

Left Atrial Appendage Closure in Japan: rules, payment and health figures

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2] Early deaths from long-term diseases: 7.9% in 2023, the latest WHO figure for Japan.⁠[3]

[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[2] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how left Atrial Appendage Closure products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Left Atrial Appendage Closure right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Left Atrial Appendage Closure in context

Japan compared

  • Early deaths from long-term diseases: 7.9% (2023). World: 17.2% (2023). 15th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Left Atrial Appendage Closure market in Japan?
Placeholder estimate: about $132.5 Mn in 2025, rising to about $511.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Left Atrial Appendage Closure market in Japan growing?
Placeholder estimate: about 16.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Left Atrial Appendage Closure market report cover?
The report splits the market by product (Endocardial Devices, Epicardial Devices), setting (Hospitals, Cardiac Centers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Left Atrial Appendage Closure market?
Key players include Boston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical and Lifetech Scientific.
What is driving the Left Atrial Appendage Closure market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.
Who regulates Left Atrial Appendage Closure in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
What does WHO report for Japan?
Early deaths from long-term diseases: 7.9% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in Japan are 65 or older?
30.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 16 Nov 2026.
How much research is published on Left Atrial Appendage Closure?
PubMed lists 1,353 papers on Left Atrial Appendage Closure added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on cardiovascular and stroke

See the topic